Meiji Yasuda Asset Management Co. Ltd. reduced its stake in West Pharmaceutical Services, Inc. by 6.7% this past quarter. In doing so, the institutional investor sold 737 shares and retained 10,248 shares of the medical instruments supplier, reflecting a closely watched shift in its portfolio.